
Kevin M. Johnson
Examiner (ID: 17187)
| Most Active Art Unit | 1793 |
| Art Unit(s) | 1793, 1732 |
| Total Applications | 255 |
| Issued Applications | 85 |
| Pending Applications | 85 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18970106
[patent_doc_number] => 20240050198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => DENTAL KIT COMPRISING A DENTAL ALIGNER OR A MOUTH TRAY AND DISSOLVABLE FILMS
[patent_app_type] => utility
[patent_app_number] => 18/031784
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031784
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031784 | DENTAL KIT COMPRISING A DENTAL ALIGNER OR A MOUTH TRAY AND DISSOLVABLE FILMS | Oct 21, 2021 | Pending |
Array
(
[id] => 17532391
[patent_doc_number] => 20220111000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => LISINOPRIL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/507144
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507144
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507144 | Lisinopril formulations | Oct 20, 2021 | Issued |
Array
(
[id] => 17398007
[patent_doc_number] => 20220040097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => CHEWABLE TABLET
[patent_app_type] => utility
[patent_app_number] => 17/507733
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507733 | CHEWABLE TABLET | Oct 20, 2021 | Abandoned |
Array
(
[id] => 17412710
[patent_doc_number] => 20220047614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
[patent_app_type] => utility
[patent_app_number] => 17/497813
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497813
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/497813 | Compositions and methods for protecting against airborne pathogens and irritants | Oct 7, 2021 | Issued |
Array
(
[id] => 18610721
[patent_doc_number] => 20230277451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER
[patent_app_type] => utility
[patent_app_number] => 18/030153
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030153
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030153 | A PHARMACEUTICAL FORMULATION FOR PRESSURISED METERED DOSE INHALER | Oct 7, 2021 | Pending |
Array
(
[id] => 18842621
[patent_doc_number] => 20230405025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/030439
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030439 | CANNABINOID-CONTAINING COMPOSITIONS AND USE FOR TREATING AND PREVENTING DISEASES | Oct 3, 2021 | Pending |
Array
(
[id] => 17368146
[patent_doc_number] => 20220023198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => ORAL SOLUBLE FILM CONTAINING SILDENAFIL CITRATE
[patent_app_type] => utility
[patent_app_number] => 17/488610
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17488610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/488610 | ORAL SOLUBLE FILM CONTAINING SILDENAFIL CITRATE | Sep 28, 2021 | Pending |
Array
(
[id] => 17342224
[patent_doc_number] => 20220008555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/487354
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -344
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487354 | Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery | Sep 27, 2021 | Issued |
Array
(
[id] => 17480427
[patent_doc_number] => 20220087931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE
[patent_app_type] => utility
[patent_app_number] => 17/483220
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483220 | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine | Sep 22, 2021 | Issued |
Array
(
[id] => 18724161
[patent_doc_number] => 20230338281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND AN ACTIVE AGENT
[patent_app_type] => utility
[patent_app_number] => 18/020544
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020544
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020544 | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent | Sep 22, 2021 | Issued |
Array
(
[id] => 17480428
[patent_doc_number] => 20220087932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE
[patent_app_type] => utility
[patent_app_number] => 17/483250
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483250
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483250 | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine | Sep 22, 2021 | Issued |
Array
(
[id] => 18752312
[patent_doc_number] => 20230355534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => METHOD TO ENCAPSULATE AN AQUEOUS SOLUTION COMPRISING A COMPOUND OF INTEREST IN A MATRIX
[patent_app_type] => utility
[patent_app_number] => 18/246005
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/246005 | METHOD TO ENCAPSULATE AN AQUEOUS SOLUTION COMPRISING A COMPOUND OF INTEREST IN A MATRIX | Sep 22, 2021 | Abandoned |
Array
(
[id] => 18860163
[patent_doc_number] => 20230414597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => ORODISPERSIBLE POWDER COMPOSITION COMPRISING AN ANTIHISTAMINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/253113
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253113
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253113 | ORODISPERSIBLE POWDER COMPOSITION COMPRISING AN ANTIHISTAMINE COMPOUND | Sep 21, 2021 | Pending |
Array
(
[id] => 18921278
[patent_doc_number] => 20240024282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => C-PHYCOCYANIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF PERIPHERAL NEUROPATHY
[patent_app_type] => utility
[patent_app_number] => 18/043899
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043899
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043899 | C-PHYCOCYANIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF PERIPHERAL NEUROPATHY | Sep 20, 2021 | Abandoned |
Array
(
[id] => 18953478
[patent_doc_number] => 20240041805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/044877
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044877 | PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN | Sep 16, 2021 | Pending |
Array
(
[id] => 18690824
[patent_doc_number] => 20230320979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => OIL-IN-WATER EMULSIONS FOR INTRAVITREAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 18/043939
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043939
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043939 | OIL-IN-WATER EMULSIONS FOR INTRAVITREAL ADMINISTRATION | Sep 14, 2021 | Pending |
Array
(
[id] => 17312752
[patent_doc_number] => 20210401800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/467778
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/467778 | Pharmaceutical composition | Sep 6, 2021 | Issued |
Array
(
[id] => 17297833
[patent_doc_number] => 20210393672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/463797
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463797
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463797 | BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS | Aug 31, 2021 | Abandoned |
Array
(
[id] => 19397169
[patent_doc_number] => 12071517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Therapeutic dendrimer
[patent_app_type] => utility
[patent_app_number] => 17/461655
[patent_app_country] => US
[patent_app_date] => 2021-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 29267
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17461655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/461655 | Therapeutic dendrimer | Aug 29, 2021 | Issued |
Array
(
[id] => 19135652
[patent_doc_number] => 11970583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Therapeutic dendrimer
[patent_app_type] => utility
[patent_app_number] => 17/411582
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 25338
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 288
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17411582
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/411582 | Therapeutic dendrimer | Aug 24, 2021 | Issued |